is a regenerative medicine company that is developing cell-based therapies for cardiovascular indications. Anginera, Theregen’s lead product, is an epicardial patch designed to improve cardiac function in patients.
Saints Capital | 2020 Union St., San Francisco, CA 94123 | (415) 773-2080 | eMail Us
© 2024 All Rights Reserved
© 2022 All Rights Reserved